Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Gynecologists should learn about transgender care to provide the best service.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

The document summarized various dermatology studies and case reports.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.